Overview of Thyroid Conditions Highly Affecting Women
Hypothyroidism: The Predominant Thyroid Disorder in Women
Hypothyroidism is the most common thyroid condition affecting women, occurring 6 times more frequently than in men, with prevalence rates of up to 40 per 10,000 women annually compared to only 6 per 10,000 men. 1 The condition becomes increasingly common with advancing age, affecting 4-10% of women overall, with subclinical hypothyroidism present in up to 5% of women compared to 3% of men. 2, 3
Primary Causes in Women
Hashimoto's thyroiditis (chronic autoimmune thyroiditis) accounts for 85-90% of hypothyroidism cases in women in iodine-sufficient regions like the United States. 4, 5 The autoimmune nature of this condition explains the female predominance. 6
Iatrogenic causes include radioactive iodine therapy for hyperthyroidism, thyroidectomy, and external-beam radiation to the head and neck, all resulting in permanent hypothyroidism requiring lifelong replacement. 4
Medication-induced hypothyroidism occurs with amiodarone and immune checkpoint inhibitors (anti-PD-1/PD-L1 therapy), which cause thyroid dysfunction in 5-10% of patients, rising to 20% with combination immunotherapy. 4
Worldwide, iodine deficiency remains the leading cause, particularly affecting women in developing nations and increasing risk of congenital cretinism in offspring. 4
Clinical Presentation Specific to Women
Women with hypothyroidism present with protean manifestations that particularly impact reproductive health, including abnormal menses, infertility, poor pregnancy outcomes, and increased miscarriage risk. 3, 7 Classic symptoms include:
- Fatigue, weight gain, cold intolerance, and mental slowing 2, 5
- Menstrual irregularities, infertility, and poor obstetric outcomes 3, 7
- Dry skin, hair loss, constipation, and depression 7, 5
- Bradycardia, hyperlipidemia, and myalgias 7
The thyroid gland in Hashimoto's thyroiditis is typically firm and irregular to palpation, distinguishing it from other causes. 7
Diagnostic Approach
TSH measurement is the single most important diagnostic test, with sensitivity above 98% and specificity greater than 92% for detecting thyroid dysfunction. 2, 8 TSH values below 0.1 mU/L are considered low and values above 6.5 mU/L are considered elevated. 2
- The American Thyroid Association recommends initial screening at age 35 years and every 5 years thereafter. 5
- Measure both TSH and free T4 to distinguish subclinical hypothyroidism (elevated TSH with normal free T4) from overt hypothyroidism (elevated TSH with low free T4). 8
- Anti-TPO antibodies confirm autoimmune etiology and predict 4.3% annual progression risk to overt hypothyroidism versus 2.6% in antibody-negative individuals. 8
Treatment Recommendations
Levothyroxine monotherapy is the standard treatment, administered as a single daily dose on an empty stomach, 30-60 minutes before breakfast, with the goal of restoring TSH to 0.5-1.5 mIU/L. 3, 8
For TSH >10 mIU/L, initiate levothyroxine therapy regardless of symptoms, as this level carries approximately 5% annual risk of progression to overt hypothyroidism. 8
- For patients <70 years without cardiac disease, start with full replacement dose of approximately 1.6 mcg/kg/day. 8
- For patients >70 years or with cardiac disease, start with 25-50 mcg/day and titrate gradually to avoid cardiac complications. 8
- Monitor TSH every 6-8 weeks during dose titration, then every 6-12 months once stable. 8
For TSH 4.5-10 mIU/L (subclinical hypothyroidism), treatment decisions should be individualized based on symptoms, pregnancy plans, or positive anti-TPO antibodies. 8 However, routine treatment is not recommended for asymptomatic patients in this range; instead, monitor thyroid function tests at 6-12 month intervals. 8
Critical Considerations for Women of Reproductive Age
All women planning pregnancy or who are pregnant should be screened, as even subclinical hypothyroidism is associated with preeclampsia, low birth weight, late fetal demise, lower offspring IQ, and poor cognitive development in children. 2, 3, 7
- Target TSH <2.5 mIU/L in the first trimester and maintain within trimester-specific reference ranges. 8
- Levothyroxine requirements typically increase by 25-50% during pregnancy, necessitating dose adjustment immediately upon pregnancy confirmation. 8
- Monitor TSH every 4 weeks until stable, then at minimum once per trimester. 8
Common Pitfalls to Avoid
- Approximately 25% of patients on levothyroxine are unintentionally maintained on doses sufficient to fully suppress TSH, increasing risks for atrial fibrillation, osteoporosis, fractures, and cardiac complications. 8
- Do not treat based on a single elevated TSH value, as 30-60% normalize on repeat testing. 8
- Never start thyroid hormone before ruling out adrenal insufficiency in patients with suspected central hypothyroidism, as this can precipitate life-threatening adrenal crisis. 8
- Confirm elevated TSH with repeat testing after 3-6 weeks before initiating treatment. 8
Thyroid Cancer: Higher Incidence in Women
Thyroid cancer represents <1% of all human tumors but is the most common endocrine malignancy, with incidence rates of 11.3 per 100,000 woman-years compared to 4.1 per 100,000 man-years. 9
- Papillary thyroid cancer accounts for the majority, with rates of 8.8 per 100,000 woman-years versus 2.7 per 100,000 man-years. 9
- Incidence has escalated globally over recent decades, mainly due to increased detection of micropapillary carcinomas (<2 cm) through improved diagnostic accuracy with neck ultrasound and fine needle aspiration cytology. 9
- The only established environmental risk factor is ionizing radiation exposure, with greater risk in younger age at exposure. 9
Subclinical Thyroid Disease: A Common Finding in Women
Subclinical hypothyroidism is much more common than overt disease in primary care populations, affecting up to 5% of women, with prevalence increasing with age and greater in whites than blacks. 2
- Subclinical hyperthyroidism is less common, occurring in 1.5% of women over age 60 compared to 1% of men. 2
- Subclinical hyperthyroidism has been associated with atrial fibrillation, dementia, and less clearly with osteoporosis. 2
- Evidence for dyslipidemia, atherosclerosis, and decreased quality of life in adults with subclinical hypothyroidism is inconsistent and less convincing. 2
High-Risk Populations Requiring Vigilance
Clinicians should be aware of subtle signs of thyroid dysfunction, particularly among postpartum women, elderly patients, those with high levels of radiation exposure (>20 mGy), and patients with Down syndrome. 2